SMMT

Summit Therapeutics is a drug development company that discovers and tests new medicines. Their main product in development is ivonescimab, an experimental cancer drug designed to treat lung cancer and colorectal cancer by helping the immune system fight tumor cells and cutting off blood supply to tumors. The company is currently running late-stage clinical trials testing this drug combined with chemotherapy in patients with various types of lung and colorectal cancer. They operate in the United States, Canada, Europe, Japan, Latin America, the Middle East, and Africa.